UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060061
Receipt number R000068659
Scientific Title The Effect of Cold Therapy in the Early Postoperative Period on Pain During Weight-Bearing and Weight-Bearing Ratio in Proximal Femoral Fractures
Date of disclosure of the study information 2025/12/12
Last modified on 2025/12/12 01:42:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Effect of Cold Therapy in the Early Postoperative Period on Pain During Weight-Bearing and Weight-Bearing Ratio in Proximal Femoral Fractures

Acronym

Randomized controlled trial

Scientific Title

The Effect of Cold Therapy in the Early Postoperative Period on Pain During Weight-Bearing and Weight-Bearing Ratio in Proximal Femoral Fractures

Scientific Title:Acronym

Randomized controlled trial

Region

Japan


Condition

Condition

Proximal femur fracture (femoral neck fracture, trochanteric fracture)

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Proximal femoral fractures are common in the elderly, requiring early weight-bearing and walking initiation postoperatively. Postoperative inflammation and acute pain inhibit weight-bearing on the affected side and delay walking acquisition. Therefore, methods to reduce inflammation and pain while promoting weight-bearing are needed. Icing is considered effective for reducing pain and inflammation, but no reports have examined its effects on weight-bearing rate and walking ability when applied immediately before exercise therapy. This study aimed to clarify the effects of icing immediately before exercise therapy on weight-bearing ratio, weight-bearing pain, motor function, walking ability, and CRP levels.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

The primary outcomes are affected-side weight-bearing ratio and weight-bearing pain (NRS).

Key secondary outcomes

Secondarily, knee extension strength, walking ability (FIM), balance function (FBS), and CRP levels were evaluated.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Icing was performed using wet ice made by adding 50 mL of water to 500 g of pure ice. The application site was directly above the wound, and icing was administered for four consecutive days immediately before the start of physical therapy. The intervention frequency was once daily, with each icing session lasting 20 minutes.

Interventions/Control_2

The control group did not perform icing immediately before rehabilitation, but both groups were similarly permitted to use general icing in the ward (for pain management purposes).

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Patients undergoing acute postoperative care who underwent total hip arthroplasty or intramedullary nailing for proximal femoral fractures between April and November 2025.

Key exclusion criteria

Exclusion criteria were defined as having a history of disease in the knee or ankle joint on the operative side, having a disease likely to affect blood data, or having weight-bearing restrictions postoperatively.

Target sample size

48


Research contact person

Name of lead principal investigator

1st name Keishin
Middle name
Last name Kobayashi

Organization

Koshigaya Seiwa hospital

Division name

Rehabilitation Department

Zip code

3430026

Address

Room 204, Charman Kita-Koshigaya 2 4-16-9 Kita-Koshigaya, Koshigaya City, Saitama Prefecture

TEL

09058359691

Email

keishin2525@gmail.com


Public contact

Name of contact person

1st name Keishin
Middle name
Last name Kobayashi

Organization

Koshigaya Seiwa Hospital

Division name

Rehabilitation Department

Zip code

3430856

Address

4-25-5 Yanaka, Koshigaya-city, Saitama Prefecture

TEL

048-967-2215

Homepage URL


Email

keishin2525@gmail.com


Sponsor or person

Institute

Jousai International University

Institute

Department

Personal name

Keishin Kobayashi


Funding Source

Organization

Jousai International University

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Koshigaya Seiwa Hospital

Address

4-25-5 Yanaka, Koshigaya-city, Saitama Prefecture

Tel

0489672215

Email

keishin2525@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

埼玉県


Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 12 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

48

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2025 Year 03 Month 15 Day

Date of IRB

2025 Year 09 Month 20 Day

Anticipated trial start date

2025 Year 04 Month 01 Day

Last follow-up date

2025 Year 12 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 12 Month 12 Day

Last modified on

2025 Year 12 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068659